Anemia Treatment Injection Franchise in Ahmedabad

Name: Darbot 40 Injection (Darbepoetin Alfa 40mcg)
Brand: Darbot 40 injection
Rating: 4.8 (150 reviews)

Darbepoetin Alfa Injection Supplier in Mumbai

CKD Anemia Injection Distributor in Delhi

Renal Care Injection Manufacturer in Bangalore

Hematology Injection Stockist in Hyderabad

Darbepoetin Injection Exporter in Chandigarh

Home/Products /darbepoetin-alfa-40mcg-injection

Therapeutic

ENDOCRINOLOGY and Hormonal range

Gastroenterology

General and OTC medicines

Gynecology and Fertility

Hepatology

Hypertension/ Blood Pressure

Nutraceuticals, Multivitamins and Multiminerals

Sedative or Antianxiety

Darbepoetin Alfa 40mcg Anemia Management Injection – PCD Pharma Franchise Marketing Material

darbepoetin alfa injection product video

Anemia management injection literature PDF

Darbot 40 injection

Composition : Darbepoetin alfa (40mcg) Injection

Dosage Form : Injection

Packaging Type : Pre-Filled Syringe

Packaging : 40mcg

Price : ₹1/-

Please Contact For Best Price

Darbepoetin Alfa 40mcg injection is an erythropoiesis-stimulating agent (ESA) used for managing anemia associated with chronic kidney disease and chemotherapy-induced anemia.

It works by stimulating the bone marrow to produce red blood cells, helping improve hemoglobin levels and enhancing oxygen delivery throughout the body.

This injection is commonly prescribed in chronic kidney disease management, dialysis patient care, and oncology-related anemia therapy, helping reduce fatigue and improve overall patient quality of life.

With strong clinical importance in nephrology and oncology treatment protocols, consistent hospital demand, and wide acceptance among specialists, this formulation strengthens institutional care portfolios and supports sustained therapeutic utilization.

About the Product

Darbepoetin Alfa 40mcg injection is an erythropoiesis-stimulating agent (ESA) used for managing anemia associated with chronic kidney disease and chemotherapy-induced anemia.

It works by stimulating the bone marrow to produce red blood cells, helping improve hemoglobin levels and enhancing oxygen delivery throughout the body.

Some patients may experience headache, increased blood pressure, injection site discomfort, nausea, or fatigue. In rare cases, allergic reactions, blood clots, or severe hypertension may occur and require medical attention.

Darbot 40 Injection is indicated for the treatment of anemia associated with chronic kidney disease in patients on dialysis as well as those not undergoing dialysis. It is also used to manage anemia in patients receiving chemotherapy for specific types of cancer, helping improve red blood cell levels and reduce symptoms of anemia.

This injection should be administered under the supervision of a qualified healthcare professional. Regular monitoring of hemoglobin levels and blood pressure is recommended during treatment. The dosage should be determined and adjusted by a physician based on the patient’s clinical condition and response to therapy.

Store in a refrigerator at 2°C–8°C. Do not freeze and protect from light. Keep the injection in its original packaging and out of reach of children.